Skip to main content

Advertisement

Log in

Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer’s disease

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Förstl H, Burns A, Luthert P, et al. (1993) The Lewy-body variant of Alzheimer’s disease, clinical and pathological findings. Br J Psychiatry 162:385–392

    Google Scholar 

  2. Hanyu H, Asano T, Sakurai H, et al. (2002) MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. Am J Neuroradiol 23:27–32

    Google Scholar 

  3. Langlais PJ, Thal L, Hansen L, et al. (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 43:1927–1934

    Google Scholar 

  4. Liberini P, Valerio A, Memo M, et al. (1996) Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer’s disease? Trends Pharmacol Sci 17:155–160

    Google Scholar 

  5. McKeith IG, Galasko D, Kosaka K, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

    Google Scholar 

  6. McKeith IG, Ballard CG, Perry RH, et al. (2000) Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54:1050–1058

    Google Scholar 

  7. McKhann G, Drachman D, Folstein M, et al. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 34: 939–944

    Google Scholar 

  8. Perry E, Haroutunian V, Davis KL, et al. (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. Neuroreport 5:747–749

    Google Scholar 

  9. Sasaki M, Ehara S, Tamakawa, et al. (1995) MR anatomy of the substantia innominata and findings in Alzheimer’s disease: a preliminary study. Am J Neuroradiol 16:2001–2007

    Google Scholar 

  10. Tanaka Y, Hanyu H, Sakurai H, et al. (2003) Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer’s disease patients. Dement Geriatr Cogn Disord 16:119–125

    Google Scholar 

  11. Tiraboschi P, Hansen LA, Alford M, et al. (2000) Cholinergic dysfunction in diseases with Lewy bodies. Neurology 54:407–411

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Hanyu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanyu, H., Tanaka, Y., Shimizu, . et al. Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer’s disease. J Neurol 252, 482–484 (2005). https://doi.org/10.1007/s00415-005-0611-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0611-8

Keywords

Navigation